Wed.Feb 23, 2022

article thumbnail

The Year Ahead: Insights From the DHC and Industry Executives

Eversana Intouch

Our friends at the Digital Health Coalition (DHC) recently convened a panel to discuss “The Year Ahead: Insights from Pharma Executives,” sharing their thoughts, opinions, and experiences alongside recent DHC data from a survey of pharma executives. The speakers were Jeff Fayer, Patient Experience Lead at Novartis; Dan Hoffman, Head of Digital Product Innovation at Otsuka Pharmaceutical Companies US; and R.J.

Media 52
article thumbnail

Pharma Sales in a Post-Covid World

Storyvine

Covid19 transformed sales globally – digital adoption replaced in-person meetings, sales reps were laid off or resigned. These changes are likely permanent. Virtual is here to stay, because it is more efficient and convenient. There is no “returning to normal,” so it’s time to move forward and figure out your long-term digital strategy. The pandemic affected pharma sales in three primary ways: Digital Adoption.

Sales 52
article thumbnail

Legal and Compliance Part 1: Protecting Yourself on Social Media

Verb

Social media has completely changed the landscape of direct sales. What started in message boards has transitioned to direct contact with people worldwide through social communication platforms like Facebook and Instagram. It’s a multi-laned avenue with various junctions and directions that gives you the ability to communicate, socialize and interact in ways that were virtually unheard of just fifteen or twenty years ago.

Media 52